An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis

Vaccine

Volumn 22, Issue 1, 2003, Pages 137-144

  Vilar, Mônica Magno ^a   Barrientos, Frank ^b   Almeida, Marília ^a   Thaumaturgo, Nilton ^a   Simpson, Andrew ^c   Garratt, Richard ^b   Tendler, Miriam ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Peptide; Trematodes; Vaccine

Indexed keywords

ANTHELMINTIC AGENT; ANTIGEN FH15; ANTIGEN SM14; ASPARAGINYLPHENYLALANYLASPARTYLALANYLVALYLMETHIONYLSERYLLYSYLGLYCINE; GLUTAMYLLYSYLASPARAGINYLSERYLGLUTAMYLSERYLLYSYLLEUCYLTHREONYLGLUTAMINE; GLUTAMYLLYSYLASPARAGINYLSERYLGLUTAMYLSERYLLYSYLLEUCYLTHREONYLGLUTAMINYLISOL EUCYLVALYLARGINYLGLUTAMYLVALYLASPARTYLGLYCYLASPARTYLTHREONYLMETHIONYLLYSYLTHREON YLTHREONINE; GLUTAMYLLYSYLPHENYLALANYLSERYLGLUTAMYLSERYLLYSYLLEUCYLTHREONYLGLUTAMINYLISO LEUCYLVALYLARGINYLGLUTAMYLVALYLASPARTYLGLYCYLASPARTYLTHREONYLMETHIONYLLYSYLTHREO NYLTHREONINE; GLUTAMYLLYSYLPHENYLALANYLSERYLGLUTAMYLSERYLLYSYLLEUCYLTHREONYLPHENYLALANYLA SPARTYLGLYCYLISOLEUCYLVALYLARGINYLGLUTAMYLVALYLASPARTYLGLYCYLALANYLTHREONYLMETHI ONYLLYSYLTHREONYLTHREONINE; IMMUNOLOGICAL ADJUVANT; ISOLEUCYLVALYLARGINYLGLUTAMYLVALYLASPARTYLGLYCYLASPARTYLTHREONYLMETHIONYLLY SYLTHREONYLTHREONINE; LYSYLISOLEUCYLGLYCYLTHREONYLSERYLVALYLPHENYLALANYLGLYCYLTHREONYLARGINYLTHRE ONYLSERYLLYSYLPHENYLALANYLASPARTYLALANYLTHREONYLGLUTAMYLMETHIONYLVALYLLEUCYLASPA RTYLLYSYLGLUTAMYLGLUTAMIC ACID; PARASITE ANTIGEN; PHOSPHORYL LIPID A; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VACCINE SM14; VALYLTHREONYLVALYLGLYCYLASPARTYLVALYLTHREONYLALANINE; VALYLTHREONYLVALYLGLYCYLASPARTYLVALYLTHREONYLALANYLASPARAGINYLPHENYLALANYLA SPARTYLALANYLVALYLMETHIONYLSERYLLYSYLLEUCYLGLYCINE; VALYLTHREONYLVALYLGLYCYLASPARTYLVALYLTHREONYLGLYCYLGLYCYLSERYLASPARTYLALANY LVALYLMETHIONYLSERYLLYSYLLEUCYLGLYCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN STRUCTURE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FASCIOLA HEPATICA; FASCIOLIASIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINATION;

EID: 0242364234     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00300-1     Document Type: Article

References (29)

1. Bergquist N.R. Schistosomiasis: from risk assessment to control. Trends Parasitol. 18(7):2002;309-314.
2. Boray JC. Flukes of domestic animals. In: Gaafar SM, Howard WE, Marsh RE, editors. Parasites, pests and predators. Amsterdan: Elsevier; 1985. p. 179-218.
3. Stoll N.R. This wormy world. J Parasitol. 33:1947;1-18.
4. Bundy D.A.P. This wormy world - then and now. Parasitol Today. 13:1997;407-408.
5. Chan M.S. The global burden of intestinal nematode infections - fifty years. Parasitol Today. 13:1997;438-443.
6. Bergquist N.R. Schistosomiasis vaccine development: approaches and prospect. Mem Inst Oswaldo Cruz. 90:1995;221-227.
7. Bergquist N.R. Controlling schistosomiasis by vaccination: a realistic option? Parasitol Today. 11:1997;191-194.
8. Bergquist N.R., Colley D.G. Schistosomiasis vaccines: research to development. Parasitol Today. 14:1998;99-104.
9. Capron A. Schistosomiasis: forty years war on the worm. Parasitol Today. 14:1998;379-384.
10. Tendler M., Brito C.A., Vilar M.M.et al. A Schistosoma mansoni fatty acid binding protein Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA. 93:1996;269-273.
11. Capron A., Capron M., Dombrowicz D., Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int Arch Allergy Immunol. 124:2001;9-15.
12. Maizels R.M., Holland M.J., Falcone F.H., Zang X.X., Yazdanbaklhsh M. Vaccination against helminth parasites - the ultimate challenge for vaccinologists? Immunol Rev. 171:1999;125-147.
13. Reynolds S.R., Dahl C.E., Harn D.A. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol. 152:1994;193-200.
14. Tarrab-Hazdai R., Schechtman D., Arnon R. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni. Infect Immun. 66:1998;4526-4530.
15. Ben-Yedidia T., Tarrab-Hazday R., Schechtman D., Arnon R. Intranasal administration of synthetic recombinant peptide based vaccine protects mice from infection by S. mansoni. Infect Immun. 67:1999;4360-4366.
16. Arnon R., Tarrab-Hazdai R., Steward M. A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization. Immunology. 101:2000;555-562.
17. Yang W., Jackson D.C., Zeng Q., Mc Manus D.P. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. Vaccine. 19:2000;103-113.
18. El Ridi R., Mahrous A., Afifi A., Montash M., Velek J., Jezek J. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase in associated with resistance to schistosomiasis. Scand J Immunol. 54:2001;477-485.
19. Van Regenmortel MHV, Briand JP, Muller S, Plaue S. Synthetic polypeptides as antigens. In: Burdon RH, van Knippenberg PH, editors. Laboratory techniques biochemistry and molecular biology. New York: Elsevier; 1988.
20. Vriend G. WHATIF - a molecular modeling and drug design program. J Mol Graph. 8:1990;52-57.
21. Ramos C.R.R., Vilar M.M., Nascimento A.L.T.O.et al. r-Sm14-pRSETA efficacy in experimental animals. Mem Inst Oswaldo Cruz. 96:2001;131-135.
22. Tendler M., M M., Brito C.A., Freire N.M.S., Katz N., Simpson A. Vaccination against schistosomiasis and fasciolasis with the new recombinant antigen Sm14: potential basis of a multivalent anti-helminth vaccine? Mem Inst Oswaldo Cruz. 90:1995;255-256.
23. Jones T.A., Bergfors T., Sedzik J., Yunge T. The three-dimensional structure of P2 myelin protein. EMBO J. 7:1988;1597-1604.
24. Sacchettini J.C., Gordon J.L., Banaszak L.J. The structure of crystalline Escherichia coli derived rat fatty acid binding protein at 2.5A resolution. J Biol Chem. 263:1988;5815-5819.
25. Muller-Falrow A., Egner V., Jones T.A., Rudel M., Spener F., Saenger W. Three-dimensional structure of fatty acid binding protein from bovine heart. Eur J Biochem. 199:1991;271-276.
26. Schulz GE, Schirmer RH. Patterns of folding and association of polypeptide chains. In: Principles of protein structure. Berlin: Springer.
27. Brito C.F., Caldas J.R., Coura Filho P., Correa-Oliveira R., Oliveira S.C. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon gamma and tumour necrosis factor-alpha in response to the recombinant 14 kDa S. mansoni fatty acid binding protein. Scand J Immunol. 51:2000;595-601.
28. Brito C.F., Fonseca C.T., Góes A.M., Azevedo V., Simpson A.J., Oliveira S.C. Human IgG1 and IgG3 recognition of S. mansoni 14 kDa fatty acid-binding protein. Parasite Immunol. 22:2000;41-48.
29. Ulrich JT, Myers KR. Monophosphoryl lipid A as an adjuvant - past experiences and new directions. In: Powell MF, Newman MJ, editors. Vaccine design: the subunit and adjuvant approach. New York: Plenum Press; 1995. p. 123-45.